Literature DB >> 36184696

Overview of Ongoing Clinical Trials on Radioembolization.

Matthias P Fabritius1, Jens Ricke2.   

Abstract

Entities:  

Year:  2022        PMID: 36184696     DOI: 10.1007/s00270-022-03270-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.797


× No keyword cloud information.
  2 in total

1.  Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Authors:  Richard S Finn; Shukui Qin; Masafumi Ikeda; Peter R Galle; Michel Ducreux; Tae-You Kim; Masatoshi Kudo; Valeriy Breder; Philippe Merle; Ahmed O Kaseb; Daneng Li; Wendy Verret; Derek-Zhen Xu; Sairy Hernandez; Juan Liu; Chen Huang; Sohail Mulla; Yulei Wang; Ho Yeong Lim; Andrew X Zhu; Ann-Lii Cheng
Journal:  N Engl J Med       Date:  2020-05-14       Impact factor: 91.245

2.  Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.

Authors:  David Tai; Kelvin Loke; Apoorva Gogna; Neslihan Arife Kaya; Sze Huey Tan; Tiffany Hennedige; David Ng; Farah Irani; Joycelyn Lee; Jia Qi Lim; Chow Wei Too; Matthew C H Ng; Chee Kian Tham; Justina Lam; Si Lin Koo; Hui Shan Chong; George Boon-Bee Goh; Hian Liang Huang; Nanda Venkatanarasimha; Richard Lo; Pierce K H Chow; Brian K P Goh; Alexander Chung; Han Chong Toh; Choon Hua Thng; Tony K H Lim; Joe Yeong; Weiwei Zhai; Chung Yip Chan; Su Pin Choo
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-10-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.